ANN ARBOR, Mich.--(BUSINESS WIRE)--KAI Research, Inc., a wholly owned subsidiary of Altarum Institute, will highlight its latest work around clinical trials and pharmacovigilance at the upcoming Drug Information Association (DIA) Conference, June 14-18, in Washington, DC. KAI is a full-service contract research organization (CRO) helping pharmaceutical, academic, and federal clients bring innovative drug treatments and interventions to market since 1986. KAI has supported several clients for mu